{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:44:24Z","timestamp":1775249064115,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jrnjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1053\/j.jrn.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T11:45:14Z","timestamp":1539344714000},"page":"235-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Truncal Adiposity Influences High-Density Lipoprotein Cholesterol Levels and Cardiovascular Events in Hemodialysis Patients"],"prefix":"10.1053","volume":"29","author":[{"given":"Go","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-6145","authenticated-orcid":false,"given":"Hirokazu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Koiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2018.08.011_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jacc.2017.11.011","article-title":"Obesity: pathophysiology and management","volume":"71","author":"Gadde","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jrn.2018.08.011_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.2010.493","article-title":"Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients","volume":"79","author":"Postorino","year":"2011","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2018.08.011_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.kint.2015.12.002","article-title":"Body mass index and causes of death in chronic kidney disease","volume":"89","author":"Navaneethan","year":"2016","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2018.08.011_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ndt\/gfw075","article-title":"Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis","volume":"32","author":"Ladhani","year":"2017","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2018.08.011_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ajcn\/81.3.543","article-title":"Survival advantages of obesity in dialysis patients","volume":"81","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2018.08.011_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2215\/CJN.02030213","article-title":"Risk factor paradox in CKD and ESRD: does a healthy lifestyle matter?","volume":"8","author":"Beddhu","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 4","key":"10.1053\/j.jrn.2018.08.011_bib7","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1097\/01.ASN.0000081698.10331.83","article-title":"Impact of dyslipidemia in end-stage renal disease","volume":"14","author":"Prichard","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2018.08.011_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5551\/jat.12849","article-title":"Lipid abnormalities in patients with chronic kidney disease: implications for the pathophysiology of atherosclerosis","volume":"20","author":"Keane","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"10.1053\/j.jrn.2018.08.011_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2215\/CJN.09961110","article-title":"Committee of Renal Data Registry, Japanese Society for Dialysis Therapy. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients","volume":"6","author":"Shoji","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2018.08.011_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1681\/ASN.2013080816","article-title":"HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients","volume":"26","author":"Silbernagel","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2018.08.011_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jacl.2017.12.007","article-title":"Associations of lipoproteins with cardiovascular and infection related outcomes in patients receiving hemodialysis","volume":"12","author":"Kaysen","year":"2018","journal-title":"J Clin Lipodol"},{"key":"10.1053\/j.jrn.2018.08.011_bib12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/01.ASN.0000117286.85443.7D","article-title":"Abnormal hdl apolipoprotein a-i and a-ii kinetics in hemodialysis patients: a stable isotope study","volume":"15","author":"Okubo","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2018.08.011_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/ndt\/gft370","article-title":"Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis","volume":"29","author":"Kaysen","year":"2014","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2018.08.011_bib14","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1038\/oby.2007.342","article-title":"Effect of obesity on high-density lipoprotein metabolism","volume":"15","author":"Rashid","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.jrn.2018.08.011_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1467-789X.2011.00900.x","article-title":"Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management","volume":"12","author":"van de Woestijne","year":"2011","journal-title":"Obes Rev"},{"key":"10.1053\/j.jrn.2018.08.011_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.jrn.2009.04.002","article-title":"Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients","volume":"19","author":"Kaysen","year":"2009","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2018.08.011_bib17","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/ndt\/14.10.2427","article-title":"Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients","volume":"14","author":"Odamaki","year":"1999","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2018.08.011_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.atherosclerosis.2011.10.038","article-title":"Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients","volume":"220","author":"Honda","year":"2012","journal-title":"Atherosclerosis"},{"issue":"Suppl 3","key":"10.1053\/j.jrn.2018.08.011_bib19","article-title":"K\/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease","volume":"41","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2018.08.011_bib20","doi-asserted-by":"crossref","first-page":"e0166804","DOI":"10.1371\/journal.pone.0166804","article-title":"N-terminal pro-B-type natriuretic peptide as a biomarker for loss of muscle mass in prevalent hemodialysis patients","volume":"11","author":"Ikeda","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1053\/j.jrn.2018.08.011_bib21","first-page":"S1","article-title":"Clinical practice guidelines for nutrition in chronic renal failure. K\/DOQI, National Kidney Foundation","volume":"35","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2018.08.011_bib22","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1093\/ndt\/gfr057","article-title":"Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2018.08.011_bib23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ajcn\/80.5.1222","article-title":"Truncal fat mass as a contributor to inflammation in end-stage renal disease","volume":"80","author":"Axelsson","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2018.08.011_bib24","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1053\/j.jrn.2018.08.011_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2215\/CJN.08730816","article-title":"Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients","volume":"12","author":"Chang","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2018.08.011_bib26","doi-asserted-by":"crossref","first-page":"e0177499","DOI":"10.1371\/journal.pone.0177499","article-title":"The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.jrn.2018.08.011_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner C Krane","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2018.08.011_bib28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2018.08.011_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2006070795","article-title":"Association between serum lipids and survival in hemodialysis patients and impact of race","volume":"18","author":"Kilpatrick","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2018.08.011_bib30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2215\/CJN.09830915","article-title":"Apoprotein B\/Apoprotein A-1 ratio and mortality among prevalent dialysis patients","volume":"11","author":"Sato","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2018.08.011_bib31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000441581","article-title":"Current Focuses in serum lipid abnormalities in dialysis patients","volume":"40","author":"Shoji","year":"2015","journal-title":"Blood Purif"},{"key":"10.1053\/j.jrn.2018.08.011_bib32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3945\/ajcn.112.035758","volume":"96","author":"Nazare","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2018.08.011_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/oby.20307","article-title":"Differential associations of abdominal visceral, subcutaneous adipose tissue with cardiometabolic risk factors between African and European Americans","volume":"22","author":"Liu","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.jrn.2018.08.011_bib34","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1002\/oby.20135","article-title":"Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults","volume":"21","author":"Neeland","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1053\/j.jrn.2018.08.011_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/oby.2009.180","article-title":"Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese","volume":"18","author":"Oka","year":"2010","journal-title":"Obesity (Silver Spring)"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227618301948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227618301948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:44:28Z","timestamp":1775245468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227618301948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1051227618301948"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2018.08.011","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Truncal Adiposity Influences High-Density Lipoprotein Cholesterol Levels and Cardiovascular Events in Hemodialysis Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}